» Articles » PMID: 35609226

Identification and Validation of Aging-related Genes in COPD Based on Bioinformatics Analysis

Overview
Specialty Geriatrics
Date 2022 May 24
PMID 35609226
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is a serious chronic respiratory disorder. One of the major risk factors for COPD progression is aging. Therefore, we investigated aging-related genes in COPD using bioinformatic analyses. Firstly, the Aging Atlas database containing 500 aging-related genes and the Gene Expression Omnibus database (GSE38974) were utilized to screen candidates. A total of 24 candidate genes were identified related to both COPD and aging. Using gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses, we found that this list of 24 genes was enriched in genes associated with cytokine activity, cell apoptosis, NF-κB and IL-17 signaling. Four of these genes ( and ) were determined to be significantly upregulated in clinical COPD samples and in cigarette smoke extract-exposed Beas-2B cells , and their expression was negatively correlated with predicted forced expiratory volume and forced vital capacity. In addition, the combination of expression levels of these four genes had a good discriminative ability for COPD patients (AUC = 0.794, 95% CI 0.743-0.845). All four were identified as target genes of hsa-miR-519d-3p, which was significantly down-regulated in COPD patients. The results from this study proposed that regulatory network of hsa-miR-519d-3p/ and closely associated with the progression of COPD, which provides a theoretical basis to link aging effectors with COPD progression, and may suggest new diagnostic and therapeutic targets of this disease.

Citing Articles

Multi-modal transcriptomic analysis reveals metabolic dysregulation and immune responses in chronic obstructive pulmonary disease.

Luo X, Zeng W, Tang J, Liu W, Yang J, Chen H Sci Rep. 2024; 14(1):22699.

PMID: 39349929 PMC: 11442962. DOI: 10.1038/s41598-024-71773-w.


Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects.

Qi Y, Yan Y, Tang D, Han J, Zhu X, Cui M J Inflamm Res. 2024; 17:6603-6618.

PMID: 39318994 PMC: 11421452. DOI: 10.2147/JIR.S478568.


Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015-2019.

Kim S, Lee H, Kim Y, Rhee C, Min K, Hwang Y J Korean Med Sci. 2023; 38(14):e108.

PMID: 37038644 PMC: 10086381. DOI: 10.3346/jkms.2023.38.e108.


Identification and Analysis of Necroptosis-Related Genes in COPD by Bioinformatics and Experimental Verification.

Wang Y, Su X, Yin Y, Wang Q Biomolecules. 2023; 13(3).

PMID: 36979417 PMC: 10046193. DOI: 10.3390/biom13030482.


Revealing lncRNA Biomarkers Related to Chronic Obstructive Pulmonary Disease Based on Bioinformatics.

Han H, Hao L Int J Chron Obstruct Pulmon Dis. 2022; 17:2487-2515.

PMID: 36217332 PMC: 9547624. DOI: 10.2147/COPD.S354634.

References
1.
Baker J, Vuppusetty C, Colley T, Papaioannou A, Fenwick P, Donnelly L . Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells. Sci Rep. 2016; 6:35871. PMC: 5073335. DOI: 10.1038/srep35871. View

2.
Barnes P . Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016; 138(1):16-27. DOI: 10.1016/j.jaci.2016.05.011. View

3.
Conti V, Corbi G, Manzo V, Pelaia G, Filippelli A, Vatrella A . Sirtuin 1 and aging theory for chronic obstructive pulmonary disease. Anal Cell Pathol (Amst). 2015; 2015:897327. PMC: 4506835. DOI: 10.1155/2015/897327. View

4.
Mercado N, Ito K, Barnes P . Accelerated ageing of the lung in COPD: new concepts. Thorax. 2015; 70(5):482-9. DOI: 10.1136/thoraxjnl-2014-206084. View

5.
Zhang G, Hu Y, Yuan W, Qiu H, Yu H, Du J . miR-519d-3p Overexpression Inhibits P38 and PI3K/AKT Pathway via Targeting VEGFA to Attenuate the Malignant Biological Behavior of Non-Small Cell Lung Cancer. Onco Targets Ther. 2020; 13:10257-10266. PMC: 7568445. DOI: 10.2147/OTT.S252795. View